Durbin, Senate Democrats Urge USPTO, Drug Companies To Address Errors In Patent Term Adjustment To Prevent Unwarranted Pharma Monopolies
September 18, 2024
September 18, 2024
WASHINGTON, Sept. 18 -- Sen. Richard J. Durbin, D-Illinois, issued the following news release:
Due to errors in calculating patent terms, pharmaceutical companies are able to improperly delay generic competition & continue charging monopoly prices, potentially costing consumers & taxpayers hundreds of millions of dollars in excess costs
Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, led a group of five Senate Democrats in sendi . . .
Due to errors in calculating patent terms, pharmaceutical companies are able to improperly delay generic competition & continue charging monopoly prices, potentially costing consumers & taxpayers hundreds of millions of dollars in excess costs
Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, led a group of five Senate Democrats in sendi . . .